However, interest in GLP-1 drugs, particularly Ozempic, has also been fueled in part by social media discourse and ...

Demand for weight loss drugs targeting GLP-1 has exploded in recent years, leading to disruptions in supply chains. Here are ...

Per terms, Novo could pay up to $285 million in upfront and milestone fees to Ascendis, which specializes in a kind of drug-enhancing technology.

Diabetes and weight-loss drug tirzepatide (Mounjaro, Zepbound) was listed as a contributing factor in the death of a 58-year-old nurse from Scotland who died of multiple organ failure, septic shock, ...

However, retained gastric contents were not a problem in a subset of patients taking GLP-1 drugs who had been on ... hold on Novavax's combo COVID-flu shot 3:47 PM UTC Healthcare ...

One big idea has loomed over healthcare stocks over the past two years: Demand for the new GLP-1 weight loss medicines from ...

But over the last several years, GLP-1 agonists have shot to popularity for their weight-loss capabilities, while many SGLT2 inhibitors gained expanded indications for heart and kidney benefits.

We recently published a list of 10 Best-Performing S&P 500 Stocks in the Last 3 Years. In this article, we are going to take a look at where Eli Lilly (NYSE:LLY) stands against other best performing S ...

Speaking of which, there actually even is another shot on goal in being able to target ... then the goal would be to combine them with GLP-1 agonist GSBR-1290 to treat patients with obesity.

Just a handful of networks of doctors, nurse practitioners, and physician assistants are writing prescriptions for dozens of websites offering the GLP-1 weight loss drugs, including the compounded ...

This, along with the energy and food-price shock and disrupted supply chains, was blamed for the persistently high inflation, which peaked at 9.1% in June ... This is not a sure shot, however ...